SCINAI IMMUNOTHERAPEUTICS LTD. Sublease Income
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Sublease Income of $7.17 million for the 12-month period ending 2022-12-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2023-08-18
| Period end | Sublease Income 1 month | Sublease Income 12 month |
|---|---|---|
| 2022-12-31 | $7.17M 6-K/A · filed 2023-08-18 | $7.17M 10-Q · filed 2023-05-15 |